NGT BioPharma Consultants is proud to announce Roger Nosal has joined the team as Head of Regulatory Strategy.
Prior to September 2022 he was Vice President & Head of Global Chemistry, Manufacturing & Controls at Pfizer where he was accountable for development, preparation & prosecution of global regulatory CMC applications for new commercial products & investigational applications (small & large molecules, combination products, vaccines including the COVID-19 mRNA vaccines and gene/cell therapies).
You can read more about Roger’s expertise by clicking here.
